Morning Overview on MSN

A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA

The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
Morning Overview on MSN

The FDA cleared its first blood test to flag prostate cancer in men with high PSA

An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Forbes

Pros And Cons Of Prostate Cancer Blood Tests

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
AOL

ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the ...